Healthmine’s Senior Vice President of Consulting and Professional Services Kimberly Swanson published a new article discussing the three operational and strategic areas health plans can focus on to address health equity in 2022.
To read it, click here.
Light Solutions Company, a surgical loupes and lights company, has officially announced its new line of designer loupes and frames. CEO Tina Saw DDS is incredibly excited for the shift and for bringing a product line consisting of Prada, Tory Burch, Coach and Michael Kors designer frames.
The company was founded by Saw and Dr. Thanh Luu in 2020. The first product launched was the wireless loupe light. The light was the most powerful and lightest wireless light in the dental industry, according to the company. With all the changes and additions in PPE that dentists had to implement, Light Solutions Company has quickly popularized the wireless and cordless light. Light Solutions rapidly grew and rose to the top as one of the top selling wireless light companies in the United States.
Saw and Luu believe in making the light not only incredibly lightweight and powerful, but also affordable to all dental professionals during the pandemic. “Dental professionals like ourselves were already facing a lot of financial challenges as we opened our dental practices up, and we wanted to reduce the burden and bring about a game-changing wireless light technology,” said Saw.
Today, Light Solutions is excited to merge fashion and technology into its company, while keeping its incredibly affordable pricing to its customers. “We don’t believe in the dental markup. We believe in service and quality, and we do that all by embracing e-commerce and digital technology,” said Luu. To learn more about Light Solutions Company, please click here.
Zephyr AI, a health tech company in the precision medicine sector, has closed a $18.5 million seed round. Lerner Group Investments and M-Cor Holdings led the round with participation from Allen Chao, AME Cloud Ventures, BoxGroup, MedStar Health, Roger Ferguson, Steve Oristaglio, Verily, and other strategic investors.
The company’s goal is to advance precision medicine drug discovery by ingesting complex, disparate data and applying novel machine learning algorithms to draw new insights, according to a press release.
Red Cell Partners, an investment and incubation firm that backs, builds, and scales technology-led companies in the healthcare and national security sectors, launched the company last year.
“This significant capital raise will help us expand our scope, including curating additional healthcare datasets, refining advanced machine-learning models, and deriving actionable insights for better outcomes in patient care and drug discovery,” said David Morgan, CEO of Zephyr AI.
To learn more, click here.
VivoSense, which develops novel digital endpoints from wearable sensor data, has closed a $25 million Series A financing round. The goal of the round is to accelerate the development of digital biomarkers and improve digital clinical outcome assessments. The financing will also be used for expansion and refining of the informatics platform for data analysis from wearable and connected technologies to deliver validated digital COAs for life science research.
“This strategic investment from the Debiopharm Innovation Fund and the Perceptive Xontogeny Venture (PXV) Fund will allow VivoSense to accelerate the development of real-world digital clinical measures from wearable and remote monitoring technologies,” said Dudley Tabakin, VivoSense CEO.
To read more, click here.
Picture: akindo, Getty Images
